Precigen Inc

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$5.32

-0.04 (-0.75%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 78%

Hold 2 22%

Sell 0 0%

Price Target

Analyst Price Target +1,264.1% upside

Low Target $43.64

Average Target $72.57

High Target $99.14

Current Price $5.32

Current
$5.32

Target
$72.57

$43.64 $72.57 avg $99.14

Scenario Analysis

Bear Case

$43.64

720.3%

Low target

Base Case

$72.57

+1,264.1%

Avg target

Bull Case

$99.14

+1,763.5%

High target

Risk/Reward

2.4x

Favorable

Price in Context

52-Week High

$5.47

-2.7% from high

52-Week Low

$1.38

+285.5% from low

Target vs 52W High

$72.57

+1,226.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+9.7%
AMGN Amgen Inc	Hold	44	50%	$190.87	-45.0%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+190.0%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-6.4%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.6%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-64.5%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-32.7%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-39.1%